373 related articles for article (PubMed ID: 32999024)
81. Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.
Martinez-Murillo P; Tran K; Guenaga J; Lindgren G; Àdori M; Feng Y; Phad GE; Vázquez Bernat N; Bale S; Ingale J; Dubrovskaya V; O'Dell S; Pramanik L; Spångberg M; Corcoran M; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
Immunity; 2017 May; 46(5):804-817.e7. PubMed ID: 28514687
[TBL] [Abstract][Full Text] [Related]
82. A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
Datta R; Roy Chowdhury R; Manjunath K; Hanna LE; Varadarajan R
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29584-29594. PubMed ID: 33168755
[TBL] [Abstract][Full Text] [Related]
83. Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies.
Yuan M; Cottrell CA; Ozorowski G; van Gils MJ; Kumar S; Wu NC; Sarkar A; Torres JL; de Val N; Copps J; Moore JP; Sanders RW; Ward AB; Wilson IA
Cell Host Microbe; 2019 Jun; 25(6):873-883.e5. PubMed ID: 31194940
[TBL] [Abstract][Full Text] [Related]
84. Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.
Moyo T; Ereño-Orbea J; Jacob RA; Pavillet CE; Kariuki SM; Tangie EN; Julien JP; Dorfman JR
J Virol; 2018 Jul; 92(14):. PubMed ID: 29618644
[TBL] [Abstract][Full Text] [Related]
85. Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer.
Xu Z; Walker S; Wise MC; Chokkalingam N; Purwar M; Moore A; Tello-Ruiz E; Wu Y; Majumdar S; Konrath KM; Kulkarni A; Tursi NJ; Zaidi FI; Reuschel EL; Patel I; Obeirne A; Du J; Schultheis K; Gites L; Smith T; Mendoza J; Broderick KE; Humeau L; Pallesen J; Weiner DB; Kulp DW
Nat Commun; 2022 Feb; 13(1):695. PubMed ID: 35121758
[TBL] [Abstract][Full Text] [Related]
86. [Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination].
Vzorov AN; Uryvaev LV
Mol Biol (Mosk); 2017; 51(6):945-957. PubMed ID: 29271959
[TBL] [Abstract][Full Text] [Related]
87. Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.
Malherbe DC; Pissani F; Sather DN; Guo B; Pandey S; Sutton WF; Stuart AB; Robins H; Park B; Krebs SJ; Schuman JT; Kalams S; Hessell AJ; Haigwood NL
J Virol; 2014 Nov; 88(22):12949-67. PubMed ID: 25210191
[TBL] [Abstract][Full Text] [Related]
88. Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.
Morris CD; Azadnia P; de Val N; Vora N; Honda A; Giang E; Saye-Francisco K; Cheng Y; Lin X; Mann CJ; Tang J; Sok D; Burton DR; Law M; Ward AB; He L; Zhu J
mBio; 2017 Feb; 8(1):. PubMed ID: 28246356
[TBL] [Abstract][Full Text] [Related]
89. Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers.
Bontjer I; Melchers M; Tong T; van Montfort T; Eggink D; Montefiori D; Olson WC; Moore JP; Binley JM; Berkhout B; Sanders RW
PLoS One; 2013; 8(6):e67484. PubMed ID: 23840716
[TBL] [Abstract][Full Text] [Related]
90. Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.
Hessell AJ; Malherbe DC; Pissani F; McBurney S; Krebs SJ; Gomes M; Pandey S; Sutton WF; Burwitz BJ; Gray M; Robins H; Park BS; Sacha JB; LaBranche CC; Fuller DH; Montefiori DC; Stamatatos L; Sather DN; Haigwood NL
J Immunol; 2016 Apr; 196(7):3064-78. PubMed ID: 26944928
[TBL] [Abstract][Full Text] [Related]
91. Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.
Leaman DP; Lee JH; Ward AB; Zwick MB
J Virol; 2015 Jul; 89(13):6725-45. PubMed ID: 25878116
[TBL] [Abstract][Full Text] [Related]
92. Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.
Sliepen K; Ozorowski G; Burger JA; van Montfort T; Stunnenberg M; LaBranche C; Montefiori DC; Moore JP; Ward AB; Sanders RW
Retrovirology; 2015 Sep; 12():82. PubMed ID: 26410741
[TBL] [Abstract][Full Text] [Related]
93. Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice.
Kosztyu P; Kuchar M; Cerny J; Barkocziova L; Maly M; Petrokova H; Czernekova L; Liskova V; Raskova Kafkova L; Knotigova P; Masek J; Turanek J; Maly P; Raska M
EBioMedicine; 2019 Sep; 47():247-256. PubMed ID: 31544770
[TBL] [Abstract][Full Text] [Related]
94. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
[TBL] [Abstract][Full Text] [Related]
95. Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.
Nkolola JP; Peng H; Settembre EC; Freeman M; Grandpre LE; Devoy C; Lynch DM; La Porte A; Simmons NL; Bradley R; Montefiori DC; Seaman MS; Chen B; Barouch DH
J Virol; 2010 Apr; 84(7):3270-9. PubMed ID: 20053749
[TBL] [Abstract][Full Text] [Related]
96. Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design.
Rantalainen K; Berndsen ZT; Murrell S; Cao L; Omorodion O; Torres JL; Wu M; Umotoy J; Copps J; Poignard P; Landais E; Paulson JC; Wilson IA; Ward AB
Cell Rep; 2018 Jun; 23(11):3249-3261. PubMed ID: 29898396
[TBL] [Abstract][Full Text] [Related]
97. Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.
Julien JP; Lee JH; Ozorowski G; Hua Y; Torrents de la Peña A; de Taeye SW; Nieusma T; Cupo A; Yasmeen A; Golabek M; Pugach P; Klasse PJ; Moore JP; Sanders RW; Ward AB; Wilson IA
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11947-52. PubMed ID: 26372963
[TBL] [Abstract][Full Text] [Related]
98. HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
LaBranche CC; McGuire AT; Gray MD; Behrens S; Kwong PDK; Chen X; Zhou T; Sattentau QJ; Peacock J; Eaton A; Greene K; Gao H; Tang H; Perez LG; Chen X; Saunders KO; Kwong PD; Mascola JR; Haynes BF; Stamatatos L; Montefiori DC
PLoS Pathog; 2018 Nov; 14(11):e1007431. PubMed ID: 30395637
[TBL] [Abstract][Full Text] [Related]
99. The HIV-1 envelope glycoprotein structure: nailing down a moving target.
Ward AB; Wilson IA
Immunol Rev; 2017 Jan; 275(1):21-32. PubMed ID: 28133813
[TBL] [Abstract][Full Text] [Related]
100. Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.
Spencer DA; Malherbe DC; Vázquez Bernat N; Ádori M; Goldberg B; Dambrauskas N; Henderson H; Pandey S; Cheever T; Barnette P; Sutton WF; Ackerman ME; Kobie JJ; Sather DN; Karlsson Hedestam GB; Haigwood NL; Hessell AJ
J Immunol; 2021 Mar; 206(5):999-1012. PubMed ID: 33472907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
